Deregulated Fcγ receptor expression in patients with CIDP

di Quast, Isaak, Cueni, Flavio, Nimmerjahn, Falk, Tackenberg, Björn, Lünemann, Jan D.
Pubblicato in Neurol Neuroimmunol Neuroinflamm (2015)

Terminal complement activation is increased and associated with disease severity in CIDP

di Quast, Isaak, Keller, Christian W., Hiepe, Falk, Tackenberg, Björn, Lünemann, Jan D.
Pubblicato in Ann Clin Transl Neurol (2016)

MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination

di Tietz, Silvia M., Hofmann, Regina, Thomas, Tobias, Tackenberg, Björn, Gaestel, Matthias, Berghoff, Martin
Pubblicazione 2014

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

di Lünemann, Jan D., Jelčić, Ilijas, Roberts, Susanne, Lutterotti, Andreas, Tackenberg, Björn, Martin, Roland, Münz, Christian
Pubblicazione 2008

Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

di Tackenberg, Björn, Jelčić, Ilijas, Baerenwaldt, Anne, Oertel, Wolfgang H., Sommer, Norbert, Nimmerjahn, Falk, Lünemann, Jan D.
Pubblicazione 2009

Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

di Hennerici, Tina, Pollmann, Robert, Schmidt, Thomas, Seipelt, Maria, Tackenberg, Björn, Möbs, Christian, Ghoreschi, Kamran, Hertl, Michael, Eming, Rüdiger
Pubblicato in PLoS One (2016)

Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays

di Becker, Anne, Ludwig, Nicole, Keller, Andreas, Tackenberg, Björn, Eienbröker, Christian, Oertel, Wolfgang H., Fassbender, Klaus, Meese, Eckart, Ruprecht, Klemens
Pubblicazione 2013

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Resu...

di Ziemssen, Tjalf, Lang, Michael, Tackenberg, Björn, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Medin, Jennie, Cornelissen, Christian
Pubblicato in Neurotherapeutics (2017)

Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TO...

di Gold, Ralf, Schlegel, Eugen, Elias-Hamp, Birte, Albert, Christian, Schmidt, Stephan, Tackenberg, Björn, Xiao, James, Schaak, Tom, Salmen, Hans Christian
Pubblicato in Ther Adv Neurol Disord (2018)

Preference-based Health status in a German outpatient cohort with multiple sclerosis

di Reese, Jens Peter, Wienemann, Gabriele, John, Axel, Linnemann, Alexandra, Balzer-Geldsetzer, Monika, Mueller, Ulrich Otto, Eienbröker, Christian, Tackenberg, Björn, Dodel, Richard
Pubblicazione 2013

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German clai...

di Ohlmeier, Christoph, Gothe, Holger, Haas, Judith, Osowski, Ulrike, Weinhold, Carina, Blauwitz, Sarah, Schmedt, Niklas, Galetzka, Wolfgang, Berkemeier, Fabian, Tackenberg, Björn, Stangel, Martin
Pubblicato in PLoS One (2020)

Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Tr...

di Tackenberg, Björn, Schneider, Maximilian, Blaes, Franz, Eienbröker, Christian, Schade-Brittinger, Carmen, Wellek, Anne, Deschauer, Marcus, Eickmann, Markus, Klenk, Hans-Dieter, Müller, Hans-Helge, Sommer, Norbert
Pubblicato in EBioMedicine (2018)

Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany

di Ziemssen, Tjalf, Lang, Michael, Tackenberg, Björn, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Couto, C. Anne-Marie, Findlay, John A., Cornelissen, Christian
Pubblicato in Neurol Neuroimmunol Neuroinflamm (2019)

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

di Quast, Isaak, Keller, Christian W., Maurer, Michael A., Giddens, John P., Tackenberg, Björn, Wang, Lai-Xi, Münz, Christian, Nimmerjahn, Falk, Dalakas, Marinos C., Lünemann, Jan D.
Pubblicato in J Clin Invest (2015)

Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome—From Pemphigus to Lichenoid Dermatitis

di Solimani, Farzan, Maglie, Roberto, Pollmann, Robert, Schmidt, Thomas, Schmidt, Ansgar, Ishii, Norito, Tackenberg, Björn, Kirschbaum, Andreas, Didona, Dario, Pickert, Julia, Eming, Rüdiger, Hashimoto, Takashi, Hertl, Michael
Pubblicato in Front Immunol (2019)

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple s...

di Ziemssen, Tjalf, Gass, Achim, Wuerfel, Jens, Bayas, Antonios, Tackenberg, Björn, Limmroth, Volker, Linker, Ralf, Mäurer, Mathias, Haas, Judith, Stangel, Martin, Meergans, Matthias, Harlin, Olof, Hartung, Hans-Peter
Pubblicato in BMC Neurol (2016)

Impaired IFN-γ production and proliferation of NK cells in Multiple Sclerosis

di Lünemann, Anna, Tackenberg, Björn, DeAngelis, Tracy, Barreira da Silva, Rosa, Messmer, Brady, Vanoaica, Liliana D., Miller, Aaron, Apatoff, Brian, Lublin, Fred D., Lünemann, Jan D., Münz, Christian
Pubblicazione 2011

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

di Melzer, Nico, Ruck, Tobias, Fuhr, Peter, Gold, Ralf, Hohlfeld, Reinhard, Marx, Alexander, Melms, Arthur, Tackenberg, Björn, Schalke, Berthold, Schneider-Gold, Christiane, Zimprich, Fritz, Meuth, Sven G., Wiendl, Heinz
Pubblicato in J Neurol (2016)

Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

di Srivastava, Rajneesh, Aslam, Muhammad, Kalluri, Sudhakar Reddy, Schirmer, Lucas, Buck, Dorothea, Tackenberg, Björn, Rothhammer, Veit, Chan, Andrew, Gold, Ralf, Berthele, Achim, Bennett, Jeffrey L., Korn, Thomas, Hemmer, Bernhard
Pubblicato in N Engl J Med (2012)

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA stu...

di Léger, Jean-Marc, De Bleecker, Jan L, Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Shebl, Amgad, Bauhofer, Artur, Zenker, Othmar, Merkies, Ingemar S J
Pubblicazione 2013